Mechanical assistance of the circulation during cardiogenic shock

Current Opinion in Critical Care

Volumn 17, Issue 5, 2011, Pages 425-438

  Pitsis, Antonis A ^a   Aikaterini, Visouli N ^a  

^a St Lukes Hospital   (Greece)

Author keywords

cardiogenic shock; cardiopulmonary resuscitation; long term continuous flow biventricular support; long term mechanical circulatory support; short term mechanical circulatory support

Indexed keywords

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; ASSISTED CIRCULATION; BIVENTRICULAR ASSIST DEVICE; CARDIOGENIC SHOCK; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CORONARY HEMODYNAMICS; DISEASE COURSE; EARLY INTERVENTION; EXTRACORPOREAL OXYGENATION; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MORTALITY; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; RESUSCITATION; REVIEW; SYSTOLIC BLOOD PRESSURE; THROMBOEMBOLISM; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT INDICATION;

ASSISTED CIRCULATION; CARDIOPULMONARY RESUSCITATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; PATIENT SELECTION; SHOCK, CARDIOGENIC;

EID: 80052728508     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32834a75c1     Document Type: Review

References (109)

1. Pitsis AA, Visouli AN. Chapter 52. The ESC textbook of intensive and acute cardiac care. European Society of Cardiology: Oxford University Press; 2011.
2. Haines NM, Rycus PT, Zwischenberger JB, et al. Extracorporeal Life Support Registry Report 2008: neonatal and pediatric cardiac cases. ASAIO J 2009; 55:111-116.
3. Pitsis AA, Visouli A. Mechanical circulatory support in the ICCU. Acute Card Care 2009; 11:204-215.
4. Rastan AJ, Dege A,Mohr M, et al. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010; 139:302-311; 311.e1.
5. Elsharkawy HA, Li L, Esa WA, et al. Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery. J Cardiothorac Vasc Anesth 2010; 24:946-951.
6. Wu MY, Lin PJ, Lee MY, et al. Using extracorporeal life support to resuscitate adult postcardiotomy cardiogenic shock: treatment strategies and predictors of short-term and midterm survival. Resuscitation 2010; 81:1111-1116.
7. Hei F, Lou S, Li J, et al. Five-year results of 121 consecutive patients treated with extracorporeal membrane oxygenation at Fu Wai Hospital. Artif Organs 2011; 35:572-578.
8. Mayer E, Jenkins D, Lindner J, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg 2011; 141:702-710.
9. Chen YC, Tsai FC, Chang CH, et al. Prognosis of patients on extracorporeal membrane oxygenation: the impact of acute kidney injury on mortality. Ann Thorac Surg 2011; 91:137-142.
10. Yan X, Jia S, Meng X, et al. Acute kidney injury in adult postcardiotomy patients with extracorporeal membrane oxygenation: evaluation of the RIFLE classification and the Acute Kidney Injury Network criteria. Eur J Cardiothorac Surg 2010; 37:334-338.
11. Formica F, Avalli L, Colagrande L, et al. Extracorporeal membrane oxygenation to support adult patients with cardiac failure: predictive factors of 30-day mortality. Interact Cardiovasc Thorac Surg 2010; 10:721-726.
12. Russo CF, Cannata A, Lanfranconi M, et al. Veno-arterial extracorporeal membrane oxygenation using Levitronix centrifugal pump as bridge to decision for refractory cardiogenic shock. J Thorac Cardiovasc Surg 2010; 140:1416-1421.
13. Hsu PS, Chen JL, Hong GJ, et al. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg 2010; 37:328-333.
14. Wang J, Han J, Jia Y, et al. Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. Ann Thorac Surg 2009; 88:1897-1903.
15. Rood KL, Teele SA, Barrett CS, et al. Extracorporeal membrane oxygenation support after the Fontan operation. J Thorac Cardiovasc Surg 2011. [Epub ahead of print]
16. Gazit AZ, Gandhi SK, Canter C. Mechanical circulatory support of the critically ill child awaiting heart transplantation. Curr Cardiol Rev 2010; 6:46-53.
17. Matsumiya G, Saitoh S, Sawa Y. Extracorporeal assist circulation for heart failure. Circ J 2009; 73 (Suppl A):A42-A47.
18. Bhama JK, Kormos RL, Toyoda Y, et al. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant 2009; 28:971-976.
19. Haft JW, Pagani FD, Romano MA, et al. Short- and long-term survival of patients transferred to a tertiary care center on temporary extracorporeal circulatory support. Ann Thorac Surg 2009; 88:711-717.
20. Gandhi DA, Shrewsberry T. Thromboelastograph guided management of a patient requiring Abiomed biventricular support with consumptive coagulopathy. J Extra Corpor Technol 2011; 43:26-29.
21. Netuka I, Szarszoi O, Maly J, et al. Comprehensive management of severe intestinal bleeding in a patient supported for 94 days by the biventricular Levitronix CentriMag system. Heart Surg Forum 2010; 13:E409-E410.
22. Hetzer R, Potapov EV, Alexi-Meskishvili V, et al. Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg 2011; 141:616e1-623e1.
23. John R, Long JW, Massey HT, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg 2011; 141:932-939.
24. Camboni D, Philipp A, Haneya A, et al. Serial use of an interventional lung assist device and a ventricular assist device. ASAIO J 2010; 56:270-272.
25. Philipp A, Arlt M, Amann M, et al. First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport. Interact Cardiovasc Thorac Surg 2011; 12:978-981.
26. Arlt M, Philipp A, Voelkel S, et al. Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-ofcentre cardiogenic shock. Eur J Cardiothorac Surg 2011. [Epub ahead of print]
27. Pitsis AA, Kelpis TG, Visouli AN, et al. Left ventricular assist device as a bridge to surgery in postinfarction ventricular septal defect. J Thorac Cardiovasc Surg 2008; 135:951-952. (Pubitemid 351417946)
28. La Torre MW, Centofanti P, Attisani M, et al. Posterior ventricular septal defect in presence of cardiogenic shock: early implantation of the impella recover LP 5.0 as a bridge to surgery. Tex Heart Inst J 2011; 38:42-49.
29. Gariboldi V, Grisoli D, Tarmiz A, et al. Mobile extracorporeal membrane oxygenation unit expands cardiac assist surgical programs. Ann Thorac Surg 2010; 90:1548-1552.
30. Sheu JJ, Tsai TH, Lee FY, et al. Early extracorporeal membrane oxygenatorassisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38:1810-1817.
31. Anderson M, Smedira N, Samuels L, et al. Use of the AB5000 ventricular assist device in cardiogenic shock after acute myocardial infarction. Ann Thorac Surg 2010; 90:706-712.
32. Bell BP, Iqtidar AF, Pyne CT. Impella assisted transradial coronary intervention in patients with acute coronary syndromes and cardiogenic shock: case series. Catheter Cardiovasc Interv 2011. doi: 10.1002/ccd.23104. [Epub ahead of print]
33. Hsu KH, Chi NH, Yu HY, et al. Extracorporeal membranous oxygenation support for acute fulminant myocarditis: analysis of a single center's experience. Eur J Cardiothorac Surg 2011. [Epub ahead of print]
34. Lin CT, Hsu PS, Chen BC, et al. Successful treatment of acute fulminant myocarditis with double sets of extracorporeal membrane oxygenation: report of a case and review of the literature. Thorac Cardiovasc Surg 2010; 58:433-435.
35. Mirabel M, Luyt CE, Leprince P, et al. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 2011; 39:1029-1035.
36. Rajagopal SK, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization Registry. Crit Care Med 2010; 38:382-387.
37. Teele SA, Allan CK, Laussen PC, et al. Management and outcomes in pediatric patients presenting with acute fulminant myocarditis. J Pediatr 2011; 158:638.e1-643.e1.
38. Pages ON, Aubert S, Combes A, et al. Paracorporeal pulsatile biventricular assist device versus extracorporal membrane oxygenation- extracorporal life support in adult fulminant myocarditis. J Thorac Cardiovasc Surg 2009; 137:194-197.
39. Andrade JG, Al-Saloos H, Jeewa A, et al. Facilitated cardiac recovery in fulminant myocarditis: pediatric use of the Impella LP 5.0 pump. J Heart Lung Transplant 2010; 29:96-97.
40. Fan Y, Weng YG, Xiao YB, et al. Outcomes of ventricular assist device support in young patients with small body surface area. Eur J Cardiothorac Surg 2011; 39:699-704.
41. Yeen WC, Haas G, Mehmood SA, Crestanello JA. Relapse of giant cell myocarditis supported with veno-arterial extra-corporeal membrane oxygenation. Interact Cardiovasc Thorac Surg 2011; 12:829-831.
42. Morales DL, Almond CS, Jaquiss RD, et al. Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device. J Heart Lung Transplant 2011; 30:1-8.
43. Humpl T, Furness S, Gruenwald C, et al. The Berlin Heart EXCOR Pediatrics: The SickKids Experience 2004-2008. Artif Organs 2010; 34:1082-1086.
44. Sivarajan VB, Best D, Brizard CP, et al. Improved outcomes of paediatric extracorporeal support associated with technology change. Interact Cardiovasc Thorac Surg 2010; 11:400-405.
45. Yoda M, Hata M, Sezai A, Minami K. A case report of central extracorporeal membrane oxygenation after implantation of a left ventricular assist system: femoral vein and left atrium cannulation for ECMO. Ann Thorac Cardiovasc Surg 2009; 15:408-411.
46. Potapov EV, Stepanenko A, Kukucka M, et al. Prediction of survival in patients with cardiogenic shock and multiorgan failure treated with biventricular assist device. ASAIO J 2010; 56:273-278.
47. Gevaert S, Van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and 'bridge to' therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care 2011; 15:R93. [Epub ahead of print]
48. Nathan M, Camacho M, Hardin JT, Starr JP. Abiomed biventricular assist device as a bridge to transplantation in a 14-year-old with cardiomyopathy resulting from ventricular noncompaction. Pediatr Cardiol 2010; 31:1249-1251.
49. Jeewa A, Manlhiot C, McCrindle BW, et al. Outcomes with ventricular assist device versus extracorporeal membrane oxygenation as a bridge to pediatric heart transplantation. Artif Organs 2010; 34:1087-1091.
50. Beyer AT, Hui PY, Hauesslein E. The Impella 2.5 l for percutaneous mechanical circulatory support in severe humoral allograft rejection. J Invasive Cardiol 2010; 22:E37-E39.
51. Thomas HL, Dronavalli VB, Parameshwar J, et al., on behalf of the Steering Group of the UK Cardiothoracic Transplant Audit. Incidence and outcome of Levitronix CentriMag support as rescue therapy for early cardiac allograft failure: a United Kingdom national study. Eur J Cardiothorac Surg 2011. [Epub ahead of print]
52. Marasco SF, Vale M, Pellegrino V, et al. Extracorporeal membrane oxygenation in primary graft failure after heart transplantation. Ann Thorac Surg 2010; 90:1541-1546.
53. Haj-Yahia S, Birks EJ, Amrani M, et al. Bridging patients after salvage from bridge to decision directly to transplant by means of prolonged support with the CentriMag short-term centrifugal pump. J Thorac Cardiovasc Surg 2009; 138:227-230.
54. Hsu LM, Ko WJ, Wang CH. Extracorporeal membrane oxygenation rescues thyrotoxicosis-related circulatory collapse. Thyroid 2011; 21:439-441.
55. Abuissa H, Roshan J, Lim B, Asirvatham SJ. Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia. J Cardiovasc Electrophysiol 2010; 21:458-461.
56. Akay MH, Frazier OH. Impella Recover 5.0 assisted coronary artery bypass grafting. J Card Surg 2010; 25:606-607.
57. Webb DP, Jackson D, Kasasbeh ES, et al. Novel multifunctional life support system. J Extra Corpor Technol 2010; 42:232-234.
58. Kovacic JC, Nguyen HT, Karajgikar R, et al. The impella recover 2.5 and TandemHeart ventricular assist devices are safe and associated with equivalent clinical outcomes in patients undergoing high-risk percutaneous coronary intervention. Catheter Cardiovasc Interv 2011. [Epub ahead of print]
59. Belohlavek J, Rohn V, Jansa P, et al. Veno-arterial ECMO in severe acute right ventricular failure with pulmonary obstructive hemodynamic pattern. J Invasive Cardiol 2010; 22:365-369.
60. Thiagarajan RR, Brogan TV, Scheurer MA, et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009; 87:778-785.
61. Anderson E, Jaroszewski D, Pierce C, et al. Parallel application of extracorporeal membrane oxygenation and the CardioWest total artificial heart as a bridge to transplant. Ann Thorac Surg 2009; 88:1676-1678.
62. Lad V, Elhenawy A, Harwood S, et al. Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience. Can J Cardiol 2010; 26:467-470.
63. Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139:1316-1324.
64. Jaski BE, Ortiz B, Alla KR, et al. A 20-year experience with urgent percutaneous cardiopulmonary bypass for salvage of potential survivors of refractory cardiovascular collapse. J Thorac Cardiovasc Surg 2010; 139:753-7.e1-e2.
65. Dalton HJ, Rycus PT, Conrad SA. Update on extracorporeal life support 2004. Semin Perinatol 2005; 29:24-33. (Pubitemid 40488988)
66. Sivarajan VB, Best D, Brizard CP, et al. Duration of resuscitation prior to rescue extracorporeal membrane oxygenation impacts outcome in children with heart disease. Intensive Care Med 2011; 37:853-860.
67. Aziz TA, Singh G, Popjes E, et al. Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. J Heart Lung Transplant 2010; 29:66-71.
68. Aiyagari RM, Rocchini AP, Remenapp RT, Graziano JN. Decompression of the left atrium during extracorporeal membrane oxygenation using a transseptal cannula incorporated into the circuit. Crit Care Med 2006; 34:2603-2606. (Pubitemid 44413059)
69. Clement KC, Fiser RT, Fiser WP, et al. Single-institution experience with interhospital extracorporeal membrane oxygenation transport: a descriptive study. Pediatr Crit Care Med 2010; 11:509-513.
70. Staley LL, Dobberpuhl J, Pierce CN, et al. Bridge to decision: SWAT team approach used by Mayo Clinic Arizona's cardiac transport team. Prog Transplant 2010; 20:118-124.
71. Guirgis M, Kumar K, Zieroth S, et al. Interprovincial spoke-to-hub transport using the Impella Recover LP 5.0 left ventricular assist device as a bridge to long-term circulatory support. Can J Cardiol 2010; 26:320-322.
72. Tissot C, Buchholz H, Mitchell MB, et al. First pediatric transatlantic air ambulance transportation on a Berlin Heart EXCOR left ventricular assist device as a bridge to transplantation. Pediatr Crit Care Med 2010; 11:e24-e25.
73. Avalli L, Maggioni E, Sangalli F, et al. Percutaneous left-heart decompression during extracorporeal membrane oxygenation: an alternative to surgical and transeptal venting in adult patients. ASAIO J 2011; 57:38-40.
74. Arlt M, Philipp A, Voelkel S, et al. Extracorporeal membrane oxygenation in severe trauma patients with bleeding shock. Resuscitation 2010; 81:804-809.
75. Karimova A, Van Doorn C, Brown K, et al. Mechanical bridging to orthotopic heart transplantation in children weighing less than 10 kg: feasibility and limitations. Eur J Cardiothorac Surg 2011; 39:304-309.
76. Topilsky Y, Pereira NL, Shah DK, et al. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 2011; 4:266-275.
77. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg 2009; 208:755-761.
78. Kirklin JK, Naftel DC, Kormos RL, et al. Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010; 29:1-10.
79. INTERMACS Quarterly Statistical Report. Implant dates: June 23, 2006- December 31, 2010. April 22, 2011. The Data Collection and Analysis Center University of Alabama at Birmingham. www.intermacs.org. [Accessed 20 June 2011]
80. Pagani FD, Naftel DC, Aaronson KD, et al. Rapidly changing characteristics of patients receiving mechanically assisted circulatory support in INTERMACS. Presentation. April 21-24, 2010, International Society of Heart and Lung Transplantation, 30th Annual Meeting and Scientific Sessions. Abstract at www.intermacs.org. [Accessed 20 June 2011]
81. Kirklin JK, Naftel DC, Kormos RL, et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant 2011; 30:115-123.
82. Toole JM, Strange RG, Kirker EB, Ikonomidis JS. Novel approach to management of acute pulmonary failure during biventricular assist device insertion. J Heart Lung Transplant 2009; 28:107-109.
83. Lamarche Y, Cheung A, Ignaszewski A, et al. Comparative outcomes in cardiogenic shock patients managed with Impella microaxial pump or extracorporeal life support. J Thorac Cardiovasc Surg 2010. [Epub ahead of print] 84 Schlensak C, Schibilsky D, Siepe M, et al. Biventricular cannulation is superior regarding hemodynamics and organ recovery in patients on biventricular assist device support. J Heart Lung Transplant 2011. [Epub ahead of print]
84. Kiernan MS, Krishnamurthy B, Kapur NK. Percutaneous right ventricular assist via the internal jugular vein in cardiogenic shock complicating an acute inferior myocardial infarction. J Invasive Cardiol 2010; 22:E23-E26.
85. Pitsis AA, Visouli AN, Ninios V, Kremastinos DT. Total ventricular assist for long-term treatment of heart failure. J Thorac Cardiovasc Surg 2011; 142: 464-467.
86. Miera O, Potapov EV, Redlin M, et al. First experiences with the HeartWare ventricular assist system in children. Ann Thorac Surg 2011; 91:1256-1260.
87. Hetzer R, Krabatsch T, Stepanenko A, Potapov EV. Long-term biventricular support with the heartware implantable continuous flow pump. J Heart Lung Transplant 2010; 29:822-824.
88. Loebe M, Bruckner B, Reardon MJ, et al. Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J 2011; 7:40-44.
89. Noon GP, Loebe M. Current status of the MicroMed DeBakey Noon ventricular assist device. Tex Heart Inst J 2010; 37:652-653.
90. Slaughter MS, Rogers JG, Milano CA, et al., HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361:2241-2251.
91. Augustin P, Lasocki S, Dufour G, et al. Abdominal compartment syndrome due to extracorporeal membrane oxygenation in adults. Ann Thorac Surg 2010; 90:e40-e41.
92. Attisani M, Centofanti P, La Torre M, Rinaldi M. Multiple splenic infarctions due to septic embolization in a patient supported with Berlin Heart-EXCOR biventricular assist device. Interact Cardiovasc Thorac Surg 2011; 12:497-499.
93. Yu K, Long C, Hei F, et al. Clinical evaluation of two different extracorporeal membrane oxygenation systems: a single center report. Artif Organs 2011. [Epub ahead of print]
94. Leontiadis E, Koertke H, Bairaktaris A, Koerfer R. Thrombosis of the ascending aorta during mechanical circulatory support in a patient with cardiogenic shock. Interact Cardiovasc Thorac Surg 2010; 11:510-511.
95. Bhat TM, Waked A, Teli S, et al. Acute complication due to impella 2.5 device (superficial femoral artery thrombosis): managed successfully with novel aspiration thrombectomy catheter (pronto v3). Clin Med Insights Cardiol 2011; 5:17-21.
96. Ninios V, Visouli A, Pitsis A. Images in cardiovascular medicine. Repeated successful thrombolysis of a Jarvik 2000 left ventricular assist device in a patient with noncompaction cardiomyopathy. Circulation 2010; 121:e13-e14.
97. Bizzarro MJ, Conrad SA, Kaufman DA, Rycus P, on behalf of the ELSO Task Force on Infections, ECMO. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 2011; 12:277-281.
98. Milano CA, Naftel David C, Padera RF, et al. Infection during mechanical circulatory support: can we really expect a better outlook with continuous flow technology. Presentation. April 21-24, 2010, International Society of Heart and Lung Transplantation, 30th Annual Meeting and Scientific Sessions. Abstract at www.intermacs.org. [Accessed 20 June 2011]
99. Park SJ, Naftel DC, Slaughter MS, et al. Reducing adverse neurological events in LVAD patients: pulsatile vs. continuous flow? Presentation. April 21-24, 2010, International Society of Heart and Lung Transplantation, 30th Annual Meeting and Scientific Sessions. Abstract at www.intermacs.org. [Accessed 20 June 2011]
100. Rogers JG, Pagani FD, Kirklin JK, et al. Survival after implant of a left ventricular assist device: is it the device or is it the patient? Presentation. April 21-24, 2010, International Society of Heart and Lung Transplantation, 30th Annual Meeting and Scientific Sessions. Abstract at www.intermacs.org. [Accessed 20 June 2011]
101. Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 2005; 51:4-10. (Pubitemid 40165243)
102. Hernandez AF, Grab JD, Gammie JS, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons' National Cardiac Database. Circulation 2007; 116:606-612. (Pubitemid 47364578)
103. Starling RC, Naka Y, Boyle AJ, et al. Results of the post-U.S. Food and Drug Administration-Approval Study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol 2011; 57:1890-1898.
104. John R, Pagani FD, Naka Y, et al. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. Thorac Cardiovasc Surg 2010; 140:174-181.
105. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multiinstitutional study. J Heart Lung Transplant 2009; 28:44-50.
106. Holman WL, Kirklin JK, Naftel DC, et al. Infection after implantation of pulsatile mechanical circulatory support devices. J Thorac Cardiovasc Surg 2010; 139:1632.e2-1636.e2.
107. Matthews JC, Pagani FD, Haft JW, et al. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010; 121:214-220.
108. Smedira N. Invited commentary. Ann Thorac Surg 2011; 91:143.
109. Smedira NG, Hoercher KJ, Yoon DY, et al. Bridge to transplant experience: factors influencing survival to and after cardiac transplant. J Thorac Cardiovasc Surg 2010; 139:1295-1305; 1305.e1-e4.